Blockchain Registration Transaction Record

VERAXA Appoints Raju Willener as CFO to Drive BiTAC Oncology Pipeline

VERAXA Biotech names Raju Willener as CFO, bringing 30+ years of capital markets expertise to advance its BiTAC oncology pipeline and BiTAC-ADC platform.

The appointment of a CFO with three decades of capital-markets experience signals VERAXA's readiness to scale its operations and potentially accelerate the development of its BiTAC platform. For investors, this could mean improved financial strategy and access to funding as the company progresses toward clinical milestones. The early promise of BiTAC-ADC and T-cell engager technologies offers hope for more effective cancer treatments, making VERAXA a company to watch in the competitive oncology space.